PMHS
Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin,… Read more
PMHS (PMHS) - Total Assets
Latest total assets as of September 2025: $9.27 Million USD
Based on the latest financial reports, PMHS (PMHS) holds total assets worth $9.27 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
PMHS - Total Assets Trend (2007–2024)
This chart illustrates how PMHS’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
PMHS - Asset Composition Analysis
Current Asset Composition (December 2024)
PMHS's total assets of $9.27 Million consist of 0.8% current assets and 99.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.1% |
| Accounts Receivable | $1.84K | 0.0% |
| Inventory | $68.78K | 0.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $250.00K | 2.5% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2007–2024)
This chart illustrates how PMHS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PMHS's current assets represent 0.8% of total assets in 2024, a decrease from 100.0% in 2007.
- Cash Position: Cash and equivalents constituted 0.1% of total assets in 2024, down from 100.0% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2007.
- Asset Diversification: The largest asset category is intangible assets at 2.5% of total assets.
PMHS Competitors by Total Assets
Key competitors of PMHS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
China | CN¥12.68 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.84 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.04 Billion |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937
|
China | CN¥1.75 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.84 Billion |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126
|
China | CN¥6.56 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.26 Billion |
PMHS - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - PMHS generates 0.01x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - PMHS is currently not profitable relative to its asset base.
PMHS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.13 | 0.16 | 0.00 |
| Quick Ratio | 0.03 | 0.02 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.31 Million | $ -797.66K | $ -306.23K |
PMHS - Advanced Valuation Insights
This section examines the relationship between PMHS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.58 |
| Latest Market Cap to Assets Ratio | 0.45 |
| Asset Growth Rate (YoY) | 4078495.5% |
| Total Assets | $9.95 Million |
| Market Capitalization | $4.49 Million USD |
Valuation Analysis
Below Book Valuation: The market values PMHS's assets below their book value (0.45 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: PMHS's assets grew by 4078495.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for PMHS (2007–2024)
The table below shows the annual total assets of PMHS from 2007 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $9.95 Million | +4078495.49% |
| 2023-12-31 | $244.00 | -99.91% |
| 2022-12-31 | $261.48K | +458.76% |
| 2018-12-31 | $46.80K | +89894.23% |
| 2017-12-31 | $52.00 | 0.00% |
| 2016-12-31 | $52.00 | -99.36% |
| 2009-12-31 | $8.07K | +177.80% |
| 2008-12-31 | $2.91K | -82.41% |
| 2007-12-31 | $16.52K | -- |